Cite
MLA Citation
P. Reagan et al.. “HIGH RATE OF MORBID CENTRAL LINE ASSOCIATED COMPLICATIONS DURING TREATMENT WITH DOSE‐ADJUSTED R‐EPOCH THERAPY FOR NON‐HODGKIN LYMPHOMA.” Hematological oncology, vol. 35, n.d., pp. 413–414. http://access.bl.uk/ark:/81055/vdc_100047469150.0x000037